Clinical Trials Browser

Phase 2 × Leukemia, Plasma Cell × 90 days × Clear all

NCT07509086 2026-04-03

IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia

Phase 2 Recruiting

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma

NCT05405387 2026-03-20

IMPACT

Phase 2 Recruiting

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma

NCT05870917 2026-03-02

A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia

Phase 2 Recruiting

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell